Agreements filed with the FTC under the Medicare Prescription Drug Improvement and Modernization Act of 2003: overview of agreements filed in FY2020
Anti-inflammatory and glial effects In preclinical models, GLP-1R activation suppresses microglial activation and lowers central production of TNF-alpha, IL-1 beta, and IL-6
At 180 days follow-up, death (HR 1.10, 95% CI 0.572.14) and heart failure rehospitalization (HR 1.30, 95% CI 0.891.88) did not differ compared with those in the placebo group
1 Lilly posted $65.18 billion in FY2025 revenue, up 44.7% year-over-year, the largest growth rate among the top 20 pharma companies
An optimal index is consistently linked to better brain function and a lower risk of age-related cognitive decline
As part of the proceedings of this MDL, the Judicial Panel on Multidistrict Litigation (JPML) was asked to add the GLP-1 drug Saxenda to the MDL